Paper40972782
Impact of empagliflozin and dapagliflozin on sudden cardiac death: A systematic review and meta-analysis of adjudicated randomized evidence.
Matteucci A and 10 others. Heart Rhythm, 2026. Cited by 40 papers, by iCite.
Cite this record
ConductScience Library. Impact of empagliflozin and dapagliflozin on sudden cardiac death: A systematic review and meta-analysis of adjudicated randomized evidence. Papers, record 40972782. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40972782
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Impact of empagliflozin and dapagliflozin on sudden cardiac death: A systematic review and meta-analysis of adjudicated randomized evidence.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Glucosides | Major topic |
| Benzhydryl Compounds | Major topic |
| Death, Sudden, Cardiac | Major topic |
| Sodium-Glucose Transporter 2 Inhibitors | Major topic |
| Diabetes Mellitus, Type 2 | Major topic |
| Humans | |
| Randomized Controlled Trials as Topic |
Source PubMed
Cited by38
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42963793 | Empagliflozin's role in cardiometabolic disease treatment: an Egyptian expert's view. | Diabetol Metab Syndr | 2026 | https://conductscience.org/library/papers/42963793 | PubMed |
| 42941631 | Drug Therapies and Incident Heart Failure in Atrial Fibrillation: A Systematic Review. | J Clin Med | 2026 | https://conductscience.org/library/papers/42941631 | PubMed |
| 42694338 | Safety & efficacy of sodium glucose co-transport 2 (SGLT2) inhibitors in elderly patients with heart failure. | Front Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42694338 | PubMed |
| 42636098 | Association of triglyceride-glucose (TyG)-Derived inflammatory indices with the risk of all-cause and cardiovascular mortality in patients with chronic kidney disease: A retrospective cohort study based on NHANES 1999-2018. | Sci Prog | 2026 | https://conductscience.org/library/papers/42636098 | PubMed |
| 42491272 | Dapagliflozin Augmentation of Sacubitril/Valsartan Therapy in Patients With Heart Failure Following PCI-Treated Acute Myocardial Infarction: A Meta-Analysis of Clinical Efficacy and Safety. | Cardiol Res Pract | 2026 | https://conductscience.org/library/papers/42491272 | PubMed |
| 42466343 | Insulin resistance as a predictor of long-term adverse cardiovascular event risk in patients with atrial fibrillation following radiofrequency catheter ablation. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42466343 | PubMed |
| 42426633 | Association of naples prognostic score and systemic immune-inflammation index with left ventricular recovery in peripartum cardiomyopathy. | BMC Cardiovasc Disord | 2026 | https://conductscience.org/library/papers/42426633 | PubMed |
| 42279224 | Prognostic Value of HALP and AHEAD Scores for Predicting 1-Month Heart Failure Following Myocardial Infarction. | J Clin Med | 2026 | https://conductscience.org/library/papers/42279224 | PubMed |
| 42122989 | Early Predictors of In-Hospital Mortality and Cardiac Dysfunction in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Early Revascularization. | J Clin Med | 2026 | https://conductscience.org/library/papers/42122989 | PubMed |
| 42074843 | Predicting Sudden Cardiac Death in Heart Failure with Mildly Reduced/Preserved Left Ventricular Ejection Fraction: A Clinical Review. | J Clin Med | 2026 | https://conductscience.org/library/papers/42074843 | PubMed |
| 41976977 | Prognostic Impact of Renin-Angiotensin System Inhibitors in Revascularized Patients with Acute Myocardial Infarction and Preserved or Mildly Reduced Ejection Fraction: A Retrospective Cohort Study. | J Clin Med | 2026 | https://conductscience.org/library/papers/41976977 | PubMed |
| 41899299 | Clinical and Comorbidity-Related Factors Associated with Health-Related Quality of Life in Patients with Heart Failure: A Cross-Sectional Study. | J Clin Med | 2026 | https://conductscience.org/library/papers/41899299 | PubMed |
| 41768590 | SGLT-2 inhibitors improve cardiac function in hypertrophic cardiomyopathy: a real-world propensity score-matched study. | Front Cardiovasc Med | 2026 | https://conductscience.org/library/papers/41768590 | PubMed |
| 41753361 | Cardio-Reno-Microvascular Phenotypes and Multifactorial Cardiometabolic Target Achievement in Type 2 Diabetes. | J Clin Med | 2026 | https://conductscience.org/library/papers/41753361 | PubMed |
| 41752660 | Heart Failure and Atrial Fibrillation in Women: Pathophysiological Links, Clinical Challenges, and Therapeutic Perspectives. | Medicina (Kaunas) | 2026 | https://conductscience.org/library/papers/41752660 | PubMed |
| 41752656 | Cardio-Vasculo-Renal Benefits of SGLT2 Inhibitors in Heart Failure: A Retrospective Study from a Lower-Resource Tertiary Center. | Medicina (Kaunas) | 2026 | https://conductscience.org/library/papers/41752656 | PubMed |
| 41745353 | Genetic Variants in Potassium Channel Genes and Their Clinical Implications in Kazakhstani Patients with Cardiac Arrhythmias. | J Pers Med | 2026 | https://conductscience.org/library/papers/41745353 | PubMed |
| 41727549 | Differential cardiovascular benefits of SGLT2 inhibitors, sacubitril/valsartan, omecamtiv mecarbil, and vericiguat across heart failure phenotypes: a systematic review and meta-analysis. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/41727549 | PubMed |
| 41682737 | Patterns in Prescribing and Predictors of SGLT2 Inhibitor Administration in Patients with Heart Failure and Acute Myocardial Infarction: A Real-World Retrospective Cohort Study. | J Clin Med | 2026 | https://conductscience.org/library/papers/41682737 | PubMed |
| 41597491 | Early SGLT2 Inhibitor Therapy in Acute Coronary Syndrome: Mitigating Adverse Remodeling in High-Risk Phenotypes-A Real-World Study. | Medicina (Kaunas) | 2026 | https://conductscience.org/library/papers/41597491 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| SLC5A2 | 6524 | PubTator's text mining | https://conductscience.org/library/genes/6524 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40972782
GET https://conductscience.org/api/papers/v1/40972782/cited_by?page=2